Skip to content

H.R. 467 · 118th Congress (2023–2025)

HALT Fentanyl Act

This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

(The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.)

Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).

Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

Show official title

To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

121 days after it was introduced

This is H.R. 467’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced4 months

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. H. Morgan Griffith (R-VA-9)
Cosponsors
52 cosponsors

24 original · 28 later

52 R

  1. Rep. Rick W. Allen (R-GA-12)· Original · Jan 24, 2023
  2. Rep. Michael C. Burgess (R-TX-26)· Original · Jan 24, 2023
  3. Rep. Gus M. Bilirakis (R-FL-12)· Original · Jan 24, 2023
  4. Rep. Vern Buchanan (R-FL-16)· Original · Jan 24, 2023
  5. Rep. Larry Bucshon (R-IN-8)· Original · Jan 24, 2023
  6. Rep. Jim Banks (R-IN-3)· Original · Jan 24, 2023
  7. Rep. Troy Balderson (R-OH-12)· Original · Jan 24, 2023
  8. Rep. Kat Cammack (R-FL-3)· Original · Jan 24, 2023
  9. Rep. Earl L. "Buddy" Carter (R-GA-1)· Original · Jan 24, 2023
  10. Rep. John R. Curtis (R-UT-3)· Original · Jan 24, 2023
  11. Rep. Dan Crenshaw (R-TX-2)· Original · Jan 24, 2023
  12. Rep. Jeff Duncan (R-SC-3)· Original · Jan 24, 2023
  13. Rep. Neal P. Dunn (R-FL-2)· Original · Jan 24, 2023
  14. Rep. Scott Fitzgerald (R-WI-5)· Original · Jan 24, 2023
  15. Rep. Brett Guthrie (R-KY-2)· Original · Jan 24, 2023
  16. Rep. Richard Hudson (R-NC-9)· Original · Jan 24, 2023
  17. Rep. Diana Harshbarger (R-TN-1)· Original · Jan 24, 2023
  18. Rep. John Joyce (R-PA-13)· Original · Jan 24, 2023
  19. Rep. Robert E. Latta (R-OH-5)· Original · Jan 24, 2023
  20. Rep. Cathy McMorris Rodgers (R-WA-5)· Original · Jan 24, 2023
  21. Rep. Alexander X. Mooney (R-WV-2)· Original · Jan 24, 2023
  22. Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Jan 24, 2023
  23. Rep. Gary J. Palmer (R-AL-6)· Original · Jan 24, 2023
  24. Rep. Tim Walberg (R-MI-5)· Original · Jan 24, 2023
  25. Rep. Kelly Armstrong (R-ND)· Later · Jan 25, 2023
  26. Rep. August Pfluger (R-TX-11)· Later · Jan 25, 2023
  27. Rep. Greg Pence (R-IN-6)· Later · Jan 25, 2023
  28. Rep. Jay Obernolte (R-CA-23)· Later · Feb 2, 2023
  29. Rep. Austin Scott (R-GA-8)· Later · Feb 2, 2023
  30. Rep. Chuck Edwards (R-NC-11)· Later · Feb 8, 2023
  31. Rep. Brad Finstad (R-MN-1)· Later · Feb 8, 2023
  32. Rep. Steve Womack (R-AR-3)· Later · Feb 8, 2023
  33. Rep. Jerry L. Carl (R-AL-1)· Later · Feb 14, 2023
  34. Rep. Debbie Lesko (R-AZ-8)· Later · Feb 17, 2023
  35. Rep. Mike Garcia (R-CA-27)· Later · Feb 27, 2023
  36. Rep. Ben Cline (R-VA-6)· Later · Mar 3, 2023
  37. Rep. Juan Ciscomani (R-AZ-6)· Later · Mar 3, 2023
  38. Rep. Stephanie I. Bice (R-OK-5)· Later · Mar 7, 2023
  39. Rep. John R. Carter (R-TX-31)· Later · Mar 7, 2023
  40. Rep. John R. Moolenaar (R-MI-2)· Later · Mar 17, 2023
  41. Rep. Aaron Bean (R-FL-4)· Later · Mar 28, 2023
  42. Rep. Harold Rogers (R-KY-5)· Later · Mar 28, 2023
  43. Rep. Daniel Meuser (R-PA-9)· Later · Apr 6, 2023
  44. Rep. Mike Bost (R-IL-12)· Later · Apr 13, 2023
  45. Rep. Andy Barr (R-KY-6)· Later · May 15, 2023
  46. Rep. Anthony D'Esposito (R-NY-4)· Later · May 15, 2023
  47. Rep. Jefferson Van Drew (R-NJ-2)· Later · May 15, 2023
  48. Rep. Tim Burchett (R-TN-2)· Later · May 17, 2023
  49. Rep. Lori Chavez-DeRemer (R-OR-5)· Later · May 17, 2023
  50. Rep. Nicholas A. Langworthy (R-NY-23)· Later · May 17, 2023
  51. Rep. Carol D. Miller (R-WV-1)· Later · May 17, 2023
  52. Rep. Bruce Westerman (R-AR-4)· Later · May 17, 2023
Policy area
Crime and Law Enforcement
Subjects
  • Administrative law and regulatory procedures
  • Department of Justice
  • Drug trafficking and controlled substances
  • Licensing and registrations
  • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

3 amendments
  1. May 25, 2023 · H.Amdt. 182 · adopted
  2. May 25, 2023 · H.Amdt. 183 · adopted
  3. May 25, 2023 · H.Amdt. 184 · failed
  1. Referred to Health

    Referred to the Subcommittee on Health.

    Sources
  2. Introduced in House

    Document: Introduced in House

    Sources
  3. ▸ 11 actions · Jan 24, 2023 – May 25, 2023
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held.

      Sources
    3. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 17 - 10 .

      Sources
    4. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held.

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held.

      Sources
    6. Ordered reported

      Ordered to be Reported (Amended) by the Yeas and Nays: 27 - 19.

      Sources
    7. Committee discharged

      Committee on the Judiciary discharged.

      Sources
    8. Reported by committee

      Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-67, Part I.

      Sources
    9. H.Amdt. 182, adopted

      Offered by Rep. Max L. Miller (R-OH-7)

      On agreeing to the Miller (OH) amendment (A001) Agreed to by voice vote.

      Sources
    10. H.Amdt. 183, adopted

      Offered by Rep. Cory Mills (R-FL-7)

      On agreeing to the Mills amendment (A002) Agreed to by voice vote.

      Sources
    11. H.Amdt. 184, failed

      Offered by Rep. Brittany Pettersen (D-CO-7)

      On agreeing to the Pettersen amendment (A003) Failed by recorded vote: 190 - 233 (Roll no. 236).

      Sources
  4. Passed House

    Roll call 237

    On passage Passed by the Yeas and Nays: 289 - 133 (Roll no. 237).

    The House passed the bill.

    Document: Engrossed in House

    Sources
  5. Latest

    Referred to committee

    Received in the Senate and Read twice and referred to the Committee on the Judiciary.

    Sources
  6. Expired

    Passed House → Referred to Senate Judiciary → No further action before the 118th Congress ended.

Roll-call votes

  1. House roll call 236Failed

    On Agreeing to the Amendment

    190–233

  2. House roll call 237Passed

    On Passage

    289–133

Committees

  1. HouseEnergy and CommerceReferred Jan 24, 2023 · Markup Mar 24, 2023 · Reported May 17, 2023H. Rept. 118-67
    1. Mar 23, 2023 · Markup

    1. H. Rept. 118-67 · May 17, 2023 · Halt All Lethal Trafficking of Fentanyl Act
  2. HouseHealthReferred Jan 24, 2023 · Markup Mar 8, 2023 · Reported Mar 8, 2023 · Markup Mar 23, 2023
    1. Mar 8, 2023 · Meeting

    2. Feb 1, 2023 · Hearing

  3. HouseJudiciaryReferred Jan 24, 2023
  4. SenateJudiciaryReferred May 30, 2023

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. May 25, 2023 · House · Considered as unfinished businessCongressional Record H2602–H2605

    Halt All Lethal Trafficking of Fentanyl Act

  2. May 25, 2023 · House · Considered as unfinished businessCongressional Record H2605–H2606

    Halt All Lethal Trafficking of Fentanyl Act

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Engrossed in House
Referred in Senate
Titles (3)
  1. HALT Fentanyl Act

    Display title, Short title · Referred in Senate, Introduced in House, Reported in House, Engrossed in House

  2. Halt All Lethal Trafficking of Fentanyl Act

    Short title · Referred in Senate, Introduced in House, Reported in House, Engrossed in House

  3. To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.

    Official title · Introduced in House